ProAssurance (NYSE:PRA – Get Free Report) will be releasing its earnings data after the market closes on Monday, May 6th. Analysts expect ProAssurance to post earnings of $0.04 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
ProAssurance (NYSE:PRA – Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The insurance provider reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.09). The business had revenue of $296.96 million during the quarter, compared to analyst estimates of $252.74 million. ProAssurance had a negative net margin of 3.39% and a negative return on equity of 0.53%. ProAssurance’s revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.06 earnings per share. On average, analysts expect ProAssurance to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
ProAssurance Stock Performance
Shares of PRA opened at $13.83 on Friday. ProAssurance has a 12-month low of $11.76 and a 12-month high of $19.38. The stock has a market capitalization of $704.92 million, a P/E ratio of -18.69 and a beta of 0.21. The firm’s 50 day moving average is $12.83 and its 200-day moving average is $13.59. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.27 and a quick ratio of 0.27.
Wall Street Analyst Weigh In
Check Out Our Latest Report on ProAssurance
About ProAssurance
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Articles
- Five stocks we like better than ProAssurance
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MarketBeat Week in Review – 4/29 – 5/3
- Insider Trading – What You Need to Know
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- The Significance of Brokerage Rankings in Stock Selection
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.